Appropriate Immunization among Patients with ImmuneMediated Inflammatory Diseases (IMIDs)

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

• The aim of this RFP is to support the care of patients with Immune Mediated Inflammatory Diseases (IMIDs), including patients under traditional immunosuppressive therapies and advanced therapies, aiming to reduce the impact of vaccine-preventable diseases by improving or facilitating appropriate vaccination practices or/and addressing gaps in vaccination status in those patients.

• Through this RFP Pfizer will support Quality and/or Process improvement projects or medical education / patient awareness initiatives aiming to address the vaccination needs and gaps among patients with IMIDs. Below is a list of possible project types:

o Assessment of gaps in guideline-concordant vaccination practices – development of programs to effectively address those gaps

o Empower medical specialists (Dermatologists, Gastroenterologists, Rheumatologists) in their role of providing recommendation/advice of vaccines in real clinical practice

o Multidisciplinary vaccination care planning including efforts for organizational improvement towards vaccination team building, continuous monitoring, track progress, sharing feedback among vaccination Team

o Targeted education for providers and/or patients (clinic-based, community-based), within the construct of a measurable QI initiative

o Addressing system-oriented issues that impact vaccination practices

o Mitigating equity and access barriers to vaccination for underserved patient populations including patients who have experienced health- and/or healthcare disparities (i.e., secondary to social determinants of health)

• Projects which entail systematic and continuous actions able to demonstrate measurable outcomes via methodologically rigorous methods will be given the highest priority.

• Priority will also be given to projects that address patients who are part of a medically underserved population; this is defined as patients who have experienced health and/or healthcare system disparities secondary to social determinants of health. Priority will also be given to projects with the maximum likelihood to directly address patient vaccination needs, as demonstrated through measurable outcomes.

Grant Application due date: July 12, 2021

Agency Website

Eligibility Requirements

Geographic Scope: Global (excluding the US)

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited. However, please note that we do not anticipate supporting projects that are ONLY educational in nature, as the intent here is to support QI efforts.



Amount Description

• Individual projects requesting up to $150,000 USD will be considered. We anticipate funding up to 5 projects.

Funding Type





International Opportunities
Medical - Clinical Science
Medical - Translational

External Deadline

July 12, 2021